US MICROBICS INC
NT 10-K, 2000-12-28
PHARMACEUTICAL PREPARATIONS
Previous: STRONG MONEY MARKET FUND INC, NSAR-BT, EX-99, 2000-12-28
Next: IEA INCOME FUND VI, 8-K, 2000-12-28



                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12B-25
                           NOTIFICATION OF LATE FILING


                                                 SEC FILE NUMBER: 0-14213
                                                 CUSIP NUMBER: 902988 10 4

(CHECK ONE):
[X] Form 10-K and Form 10-KSB     [ ] Form 20-F    [ ] Form 11-K
[ ] Form 10-Q and Form 10-QSB     [ ] Form N-SAR

         FOR PERIOD ENDED:       SEPTEMBER 30, 2000

         [  ]  Transition Report on Form 10-K
         [  ]  Transition Report on Form 20-F
         [  ]  Transition Report on Form 11-K
         [  ]  Transition Report on Form 10-Q
         [  ]  Transition Report on Form N-SAR
         For the Transition Period Ended:
                                         ---------------------------------------
--------------------------------------------------------------------------------
     READ ATTACHED INSTRUCTION SHEET BEFORE PREPARING FORM. PLEASE PRINT OR TYPE
     Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
--------------------------------------------------------------------------------

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:

--------------------------------------------------------------------------------

PART I - REGISTRANT INFORMATION
--------------------------------------------------------------------------------

Full Name of Registrant                             U.S. MICROBICS, INC.
                                                    ---------------------
Former Name if Applicable
Address of Principal Executive Office
(Street and Number)                                 5922-B FARNSWORTH COURT
                                                    ------------------------
City, State and Zip Code                            CARLSBAD, CA 92005
                                                    ------------------
PART II - RULES 12B-25 (B) AND (C)
--------------------------------------------------------------------------------

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rules 12b-25 (b), the following
should be completed. (Check box if appropriate)

     [ ] (a)The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;

     [ ] (b) The subject annual report, semi-annual report; transition report on
Form 10-K, Form 20-F, 11-K, or Form N-SAR, or portion thereof will be filed on
or before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the prescribed due
date; and

     [X] (c) The accountant's statement or other exhibit required by
Rule12b-25(c) has been attached if applicable.

--------------------------------------------------------------------------------
PART III - NARRATIVE
--------------------------------------------------------------------------------

State below in reasonable detail the reasons why Form 10-K and Form 10-KSB,
20-F, 11-K, 10-Q and Form 10-QSB, N-SAR, or the transition report or portion
thereof could not be filed within the prescribed period.

Bradshaw, Smith & Co., LLP, were retained as our independent auditors on October
17, 2000. Due to the amount of time necessary to plan and perform their auditing
procedures and the extensive amount of information requested by Bradshaw Smith &
Co., LLP, the audit will not be able to completed by December 29, 2000. The
Company believes that it will be able to file this Annual Report within the
fifteen day extension period permitted by Rule 12b-25.

--------------------------------------------------------------------------------
PART IV - OTHER INFORMATION
--------------------------------------------------------------------------------

(1) Name and telephone number of person to contact in regard to this
notification

         CONRAD NAGEL                 760-918-1860 X111
--------------------------------------------------------------------------------
           (Name)                (Area Code)(Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15 (d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report (s) been filed? If answer is no,
identify report (s). [X] Yes [ ] No

(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report of portion thereof?
[ ] Yes [X] No

     If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.

                              U.S. Microbics, Inc.
--------------------------------------------------------------------------------
                  (name of Registrant as specified in charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date: DECEMBER 28, 2000             By:      /S/  CONRAD NAGEL
      -----------------                  ---------------------------------------
                                            Conrad Nagel  , CFO

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filled with the form.

--------------------------------------------------------------------------------
                                    ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
--------------------------------------------------------------------------------

<PAGE>

United States Securities and Exchange Commission
Washington, D.C. 20549


Gentlemen:


We were retained by U.S. Microbics, Inc. and Subsidiaries on October 17, 2000 as
independent auditors to report on the consolidated financial statements at
September 30, 2000 and for the fiscal year then ended. We have endeavored, with
the cooperation of the Company, to obtain the necessary information to meet the
filing requirements for Form 10-KSB, both as to form and timeliness. Due to the
amount of time necessary to plan and perform our auditing procedures and the
extensive amount of information requested by us from the Company and third
parties, we do not have all of the necessary information to complete the audit
and, as such, we will be unable to complete our audit by December 29, 2000,
which is the required filing date for the Company's annual report.



/s/ BRADSHAW, SMITH & CO., LLP

Las Vegas, Nevada
December 28, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission